Tag: inhalation products

Pediatric Formulations: GMP Considerations for Taste, Dose Flexibility and Safety GMP Guidance for Pediatric Formulations: Ensuring Taste Acceptability, Dose Adjustability and Safety Developing pediatric formulations demands specialized good manufacturing practice (GMP) considerations distinct from adult pharmaceutical manufacturing. The primary goals are to ensure palatability to enhance compliance, enable dose flexibility for varying patient weights and…

Read More “Pediatric Formulations: GMP Considerations for Taste, Dose Flexibility and Safety” »

Geriatric Dosage Forms: GMP Controls for Swallowability and Handling Comprehensive GMP Controls for Geriatric Dosage Forms: Ensuring Safe Swallowability and Handling Pharmaceutical manufacturing for geriatric patient populations imposes unique challenges that demand precise Good Manufacturing Practice (GMP) controls. Dosage forms intended for elderly patients must address the common physiological limitations such as diminished swallowing ability,…

Read More “Geriatric Dosage Forms: GMP Controls for Swallowability and Handling” »

Fixed-Dose Combinations: GMP Complexity in Blending, Compression and Release Fixed-Dose Combinations: Managing GMP Complexities in Blending, Compression, and Release Fixed-Dose Combination (FDC) pharmaceutical products have become increasingly vital in therapeutic regimens across diverse indications, offering improved patient compliance and therapeutic synergy. However, their production, particularly across multiple dosage forms such as solid oral tablets, capsules,…

Read More “Fixed-Dose Combinations: GMP Complexity in Blending, Compression and Release” »

Nasal Powder Products: GMP Controls for Device Performance and Dose Uniformity Ensuring GMP Compliance in Nasal Powder Products: Controls for Device Performance and Dose Uniformity Nasal powder products represent a unique category within pharmaceutical dosage forms, combining attributes of solid and inhalation products to deliver therapeutic agents effectively via the nasal mucosa. Their increasing clinical…

Read More “Nasal Powder Products: GMP Controls for Device Performance and Dose Uniformity” »

Inhalation Products: DPI, MDI and Nebulizer Drug-Device Combination GMP Comprehensive Step-by-Step GMP Guide for DPI, MDI and Nebulizer Drug-Device Combination Products Inhalation products are a critical category of pharmaceutical dosage forms, combining drug and device components to deliver medication directly to the respiratory tract. These combination products include Dry Powder Inhalers (DPI), Metered Dose Inhalers…

Read More “Inhalation Products: DPI, MDI and Nebulizer Drug-Device Combination GMP” »

Metered-Dose Inhalers: GMP Controls for Valve Performance and Dose Reproducibility Metered-Dose Inhalers: GMP Controls for Valve Performance and Dose Reproducibility Metered-dose inhalers (MDIs) represent a critical dosage form in pharmaceutical manufacturing, serving delivery of respiratory medicines with precise dosing and patient-friendly administration. As combination products involving drug substances, formulation excipients, and complex device components such…

Read More “Metered-Dose Inhalers: GMP Controls for Valve Performance and Dose Reproducibility” »

Dry Powder Inhalers: Powder Flow, Humidity Control and Device GMP in Pharmaceutical Manufacturing Comprehensive GMP Approach to Dry Powder Inhalers: Managing Powder Flow, Humidity, and Device Quality Dry powder inhalers (DPIs) represent a critical segment of inhalation products pivotal to respiratory therapy worldwide. Ensuring the quality of DPIs requires specialized Good Manufacturing Practice (GMP) adherence…

Read More “Dry Powder Inhalers: Powder Flow, Humidity Control and Device GMP” »

Nebulizer Solutions and Suspensions: Sterility, Preservatives and Device Interface Nebulizer Solutions and Suspensions: Ensuring Sterility, Preservative Efficacy, and Device Compatibility under GMP The manufacturing, quality assurance, and regulatory compliance of nebulizer solutions and suspensions present unique challenges within pharmaceutical Good Manufacturing Practice (GMP) frameworks. These inhalation products must fulfill stringent criteria for sterility, preservative integrity,…

Read More “Nebulizer Solutions and Suspensions: Sterility, Preservatives and Device Interface” »

Viral Vector and Gene Therapy Drug Products: ATMP-Specific GMP Challenges Viral Vector and Gene Therapy Drug Products: Navigating ATMP-Specific GMP Challenges Advanced Therapy Medicinal Products (ATMPs), such as viral vector-based gene therapies, present unique challenges in Good Manufacturing Practice (GMP) compliance. Due to their complex and sensitive nature, these drug products must adhere to stringent…

Read More “Viral Vector and Gene Therapy Drug Products: ATMP-Specific GMP Challenges” »

Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls in Dosage Forms The manufacturing of ophthalmic pharmaceutical products demands rigorous compliance with Good Manufacturing Practice (GMP) requirements specific to dosage forms. These products, being highly sensitive formulations administered directly to the eye, require strict control over…

Read More “Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls” »